Predicting and harnessing protein flexibility in the design of species-specific inhibitors of thymidylate synthase.
Fritz, T.A., Tondi, D., Finer-Moore, J.S., Costi, M.P., Stroud, R.M.(2001) Chem Biol 8: 981-995
- PubMed: 11590022 
- DOI: https://doi.org/10.1016/s1074-5521(01)00067-9
- Primary Citation of Related Structures:  
1JG0 - PubMed Abstract: 
Protein plasticity in response to ligand binding abrogates the notion of a rigid receptor site. Thus, computational docking alone misses important prospective drug design leads. Bacterial-specific inhibitors of an essential enzyme, thymidylate synthase (TS), were developed using a combination of computer-based screening followed by in-parallel synthetic elaboration and enzyme assay [Tondi et al. (1999) Chem. Biol. 6, 319-331]. Specificity was achieved through protein plasticity and despite the very high sequence conservation of the enzyme between species.
Organizational Affiliation: 
Macromolecular Structure Group, Department of Biochemistry, University of California San Francisco, 94143-0448, USA.